|
|
|
|
|
|
by refurb
2050 days ago
|
|
|
Quite an insight to switch from cancer therapy to COVID-19 vaccine Actually not at all. BioNTech's entire platform was customized RNA therapeutics that target the immune system to a particular patient's tumor. Basically cancer vaccines. |
|
|